BG100040A - Индолови производни като 5-нт1а и/или 5-нт2 лиганди - Google Patents

Индолови производни като 5-нт1а и/или 5-нт2 лиганди Download PDF

Info

Publication number
BG100040A
BG100040A BG100040A BG10004095A BG100040A BG 100040 A BG100040 A BG 100040A BG 100040 A BG100040 A BG 100040A BG 10004095 A BG10004095 A BG 10004095A BG 100040 A BG100040 A BG 100040A
Authority
BG
Bulgaria
Prior art keywords
ylmethyl
indole
compound
methoxy
alkyl
Prior art date
Application number
BG100040A
Other languages
Bulgarian (bg)
English (en)
Inventor
Quintero Myrna Gil
Vincenzo Martino
Franco Borsini
Maria Pellegrini
Marco Turconi
Ettore Giraldo
Original Assignee
Boehringer Ingelheim Italia S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia S.P.A. filed Critical Boehringer Ingelheim Italia S.P.A.
Publication of BG100040A publication Critical patent/BG100040A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
BG100040A 1993-04-08 1995-10-02 Индолови производни като 5-нт1а и/или 5-нт2 лиганди BG100040A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI930699A IT1271352B (it) 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
PCT/EP1994/001016 WO1994024125A1 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-ht1a and/or 5-ht2 ligands

Publications (1)

Publication Number Publication Date
BG100040A true BG100040A (bg) 1996-03-29

Family

ID=11365694

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100040A BG100040A (bg) 1993-04-08 1995-10-02 Индолови производни като 5-нт1а и/или 5-нт2 лиганди

Country Status (20)

Country Link
US (1) US5834493A (de)
EP (1) EP0694033A1 (de)
JP (1) JPH08508738A (de)
CN (1) CN1124960A (de)
AU (1) AU684276B2 (de)
BG (1) BG100040A (de)
BR (1) BR9406206A (de)
CA (1) CA2160020A1 (de)
CZ (1) CZ283398B6 (de)
FI (1) FI954734L (de)
HU (1) HUT74090A (de)
IL (1) IL109234A (de)
IT (1) IT1271352B (de)
NO (1) NO953967L (de)
NZ (1) NZ265055A (de)
PL (1) PL310995A1 (de)
SG (1) SG50507A1 (de)
SK (1) SK119795A3 (de)
WO (1) WO1994024125A1 (de)
ZA (1) ZA942383B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
SK285410B6 (sk) * 1997-05-09 2007-01-04 H. Lundbeck A/S Spôsob výroby sertindolu a medziproduktov
CA2317439A1 (en) 1998-01-14 1999-07-22 Wayne J. Brouillette Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
US6133287A (en) * 1998-03-24 2000-10-17 Allelix Biopharmaceuticals Inc. Piperidine-indole compounds having 5-HT6 affinity
AU3386299A (en) * 1998-04-08 1999-10-25 American Home Products Corporation N-aryloxyethylamine derivatives for the treatment of depression
CN1307576A (zh) * 1998-04-29 2001-08-08 美国家用产品公司 5-羟色胺能药物
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
DE19951360A1 (de) * 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituierte Indole
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
ATE327232T1 (de) * 2000-12-22 2006-06-15 Wyeth Corp Heterozyklylalkylindole oder -azaindole als 5- hydroxytryptamine-6 liganden
US7135479B2 (en) 2002-09-12 2006-11-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
CA2796756A1 (en) * 2010-04-22 2011-10-27 Intra-Cellular Therapies, Inc. Substituted pyrido(3',4':4,5)pyrrolo(1,2,3-de)quinoxalines for the treatment of central nervous system disorders
KR20140146192A (ko) 2012-04-14 2014-12-24 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
US9708322B2 (en) 2013-03-15 2017-07-18 Intra-Cellular Therapies, Inc. Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity
KR102373288B1 (ko) 2013-12-03 2022-03-10 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
CA2944755A1 (en) 2014-04-04 2015-10-08 Intra-Cellular Therapies, Inc. Organic compounds
US10077267B2 (en) 2014-04-04 2018-09-18 Intra-Cellular Therapies, Inc. Organic compounds
WO2017023894A1 (en) * 2015-08-03 2017-02-09 Raze Therapeutics, Inc. Mthfd2 inhibitors and uses thereof
PL3838274T3 (pl) 2016-01-26 2024-04-02 Intra-Cellular Therapies, Inc. Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN
DK3407889T3 (da) 2016-03-25 2021-08-09 Intra Cellular Therapies Inc Organiske forbindelser og deres anvendelse til behandling og forebyggelse af lidelser i centralnervesystemet
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
EP3525763B1 (de) 2016-10-12 2025-03-05 Intra-Cellular Therapies, Inc. Amorphe feste dispersionen
EP3562484B1 (de) 2016-12-29 2021-08-25 Intra-Cellular Therapies, Inc. Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalinderivate zur behandlung von erkrankungen des zns
WO2018126140A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds
RU2767410C2 (ru) 2017-03-24 2022-03-17 Интра-Селлулар Терапиз, Инк. Новые композиции и способы
WO2019023062A1 (en) 2017-07-26 2019-01-31 Intra-Cellular Therapies, Inc. ORGANIC COMPOUNDS
EP3658144B1 (de) 2017-07-26 2022-01-26 Intra-Cellular Therapies, Inc. Pyridopyrroloquinoxalinverbindungen, deren zusammensetzungen und verwendungen in therapie
CN112040940A (zh) 2018-03-23 2020-12-04 细胞内治疗公司 有机化合物
EP3801527B1 (de) 2018-06-08 2025-02-19 Intra-Cellular Therapies, Inc. Anellierte gamma-carboline zur akutbehandlung von angst oder depression
US12144808B2 (en) 2018-08-29 2024-11-19 Intra-Cellular Therapies, Inc. Compositions and methods
BR112021003655A2 (pt) 2018-08-31 2021-05-18 Intra-Cellular Therapies, Inc. métodos novos
WO2020047408A1 (en) 2018-08-31 2020-03-05 Intra-Cellular Therapies, Inc. Novel methods
WO2021007245A1 (en) 2019-07-07 2021-01-14 Intra-Cellular Therapies, Inc. Novel methods
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
PL170330B1 (pl) * 1990-10-15 1996-11-29 Pfizer Sposób wytwarzania nowych pochodnych indolu PL PL PL PL PL PL
JP3140155B2 (ja) * 1992-03-09 2001-03-05 杏林製薬株式会社 N,n’−ジ置換アミド誘導体
CA2092112A1 (en) * 1992-03-23 1993-09-24 Nobuyoshi Iwata Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use

Also Published As

Publication number Publication date
NO953967D0 (no) 1995-10-05
IT1271352B (it) 1997-05-27
EP0694033A1 (de) 1996-01-31
BR9406206A (pt) 1996-02-06
FI954734A0 (fi) 1995-10-05
FI954734A7 (fi) 1995-10-05
CZ260295A3 (en) 1996-01-17
FI954734L (fi) 1995-10-05
PL310995A1 (en) 1996-01-22
CZ283398B6 (cs) 1998-04-15
IL109234A0 (en) 1994-07-31
CA2160020A1 (en) 1994-10-27
SK119795A3 (en) 1996-04-03
SG50507A1 (en) 1998-07-20
HUT74090A (en) 1996-11-28
US5834493A (en) 1998-11-10
IL109234A (en) 1998-04-05
JPH08508738A (ja) 1996-09-17
NO953967L (no) 1995-12-05
HU9502913D0 (en) 1995-11-28
ITMI930699A1 (it) 1994-10-08
ITMI930699A0 (it) 1993-04-08
CN1124960A (zh) 1996-06-19
NZ265055A (en) 1996-09-25
AU6538294A (en) 1994-11-08
AU684276B2 (en) 1997-12-11
ZA942383B (en) 1995-10-09
WO1994024125A1 (en) 1994-10-27

Similar Documents

Publication Publication Date Title
BG100040A (bg) Индолови производни като 5-нт1а и/или 5-нт2 лиганди
RU2294932C2 (ru) Новые производные индола со сродством к рецептору 5-ht6
RU2134266C1 (ru) Производные 5-арилиндола и их применение в качестве агонистов серотонина (5-нт1)
US20040242589A1 (en) 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
EP0773942A1 (de) 4-indolderivate als serotonin agonisten und antagonisten
HUT70195A (en) Process for producing benzimidazolone derivatives and pharmaceutical preparations containing them
KR20020030126A (ko) 5―ht1b 길항제로서의 피페라진 유도체
AU765317B2 (en) 4,5,6 and 7-indole and indoline derivatives, their preparation and use
US5393761A (en) 3-arylindole compounds
JPH04253976A (ja) 新規インドール誘導体
JPH06271571A (ja) インドール、インダゾール及びベンズイソオキサゾール化合物、それらの製法およびそれらを含有する製薬組成物
US5661169A (en) 1-benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and the pharmaceutical compositions containing them
US5576336A (en) Indole derivatives as dopamine D4 antagonists
JPH04235164A (ja) 3−アリールカルボニル−1−アミノアルキル−1h−インドール含有抗緑内障組成物
CA1337202C (en) Cyclic amides which are leukotriene antagonists
US5607957A (en) Imidazole, triazole and tetrazole derivatives
RU2127732C1 (ru) Эфиры бис-фенилпиперазинникотиновой кислоты, способ их получения (варианты), фармацевтическая композиция и способ лечения расстройств центральной нервной системы
JPS6257606B2 (de)
KR100363484B1 (ko) 3-치환1-아릴인돌화합물
KR101471987B1 (ko) 일정한 cns-관련 질환을 치료하기 위한 2-알킬-인다졸 화합물
JP5536781B2 (ja) アリールスルホンアミドアミン化合物および5−ht6リガンドとしてのそれらの使用
JPH0525140A (ja) ベンズイミダゾール誘導体
KR100837035B1 (ko) 모노아민 재흡수 억제제로서의 3-아미노-1-아릴프로필 인돌
HK1135986B (en) 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands
HK1135986A1 (en) 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands